ESCMID weekly news 01.09.2020

1 September 2020: ESCMID Weekly News
Having trouble viewing this email? View in your browser.


1 September 2020

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.


The new-look ESCMID website is now live!

The ESCMID website has now been updated to a new look.

Be sure to check out the website at

› Read more

ESCMID Membership Discounts – Are you eligible?

Did you know that ESCMID offers membership discounts for selected colleagues?

The low-income country membership offers a reduced basic membership fee of EUR 7 for a selected list of countries. These members can also receive free registration to ECCVID.

In collaboration with our colleagues at the European Respiratory Society (ERS), ESCMID is proud to offer a 15%
membership discount to ERS members.

Find out more about these and other memberships on the
ESCMID website.

› Read more

ECCVID abstract results announced

The review of regular abstracts for ECCVID is now completed, and authors can check the status of their submitted abstracts in the online submission portal.

Late-breaker Abstracts are currently under review, and their results will be announced in mid-September.

› Read more


Catch ESCMID at the ERS World Village

Are you attending the virtual ERS International Congress next week (7 – 9 September 2020)?

Be sure to visit the ESCMID booth in the ERS World Village, where you can find out about current ESCMID activities and initiatives.

Find out more on the ERS website.

› Read more


ESCMID joins BioMed Alliance

We are glad to announce that, starting from 27 July 2020, ESCMID is a new member of Biomedical Alliance in Europe (BioMed Alliance).

The BioMed Alliance is the result of a unique initiative of leading European medical societies that together include more than 400,000 researchers and health professionals.

The Association shall aim to speak as a common voice of all its members in seeking to:

  • facilitate and improve biomedical research in Europe;
  • develop a framework for better training and mobility of researchers and healthcare professionals in Europe;
  • represent its members being medical associations in common policy and strategic matters;
  • improve public understanding of medical science in Europe.

The Association intends to:

  • promote excellence in European biomedical research;
  • strengthen the representation of biomedical researchers, disciplines and associations;
  • advocate for increased funding in favour of biomedical research;
  • thereby improve the health and well-being of all citizens of Europe.

 Find the latest news on BioMed Alliance by clicking here.

› Read more


CMI Highlight: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis

Hydroxychloroquine or chloroquine with or without azithromycin have been widely promoted to treat COVID-19 following early in vitro antiviral effects against SARS-CoV-2.

The present systematic review and meta-analysis, which has been also selected for a press release, aimed at assessing whether chloroquine or hydroxychloroquine with or without azithromycin decreased COVID-19 mortality compared to the standard of care.

The results of 25 observational studies, 3 randomised controlled trials and 1 interventional non-randomised study were summarized.

They show that hydroxychloroquine alone is not effective for the treatment of COVID-19 patients and that the combination of hydroxychloroquine and azithromycin increases the risk of mortality, supporting moreover current clinical recommendations such as those of the NIH which do not recommend the use of HCQ alone or in combination with azithromycin for COVID-19 patients.

Authors conclude highlighting that given the great number of studies that have evaluated HCQ alone or in combination, it seems unlikely at this stage that any efficacy will ever emerge, making unnecessary further studies evaluating these molecules.

› Read more

ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube

The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.